Jingzhan Lu
I recently joined the research group of Prof. Martin Tobin (FMedSci) as a Postdoctoral in Statistical Genetics, Epidemiology and Respiratory diseases at University of Leicester. Interested in exploring any potential collaboration or exchange, please 📧 Contact: 106316153@gms.tcu.edu.tw
PhD Graduate supervised by Dr. Harry Green, Prof. Michael Weedon and Prof. Anna Murray with a passion for Statistical Genetics of Healthcare 🧬Personal Profile @Exeter Uni
I have been privileged to work at three world-leading genetic epidemiology laboratories:
- UCL Human Genetics Lab in Psychiatry Disorders (PGC Consortium); leading by Prof. Andrew McQuillin and Prof. Karoline Kuchenbaecker
- Exeter Genetics of Complex Traits Group (GAINT, ReproGen, MAGIC and EGG Consortium); leading by Prof. Michael Weedon, Prof. Anna Murray, Prof. Inês Barroso and Prof. Rachel Freathy
- Leicester Genetic Epidemiology Group (UK Biobank BiLEVE and SpiroMeta Consortium); leading by Prof. Martin Tobin (FMedSci)

Publications
 [1]. Improved prostate cancer prediction by combining Prostate-Specific Antigen (PSA) test results with Genetic Risk Scores (GRS/PRS) Preprint available
 [2]. Impact of control selection strategies on GWAS results: a study of prostate cancer in the UK Biobank Briefings in Bioinformatics
 [3]. Determinants of repeat miscarriage among adult women of reproductive age in Guanggu, Wuhan, China BMC Women’s Health
 [4]. Prostate cancer risk-stratification using proteomic estimation of KLK3 improves accuracy in screening applications: a population-based cohort study in the UK Biobank Preprint available
 [5]. Uncovering the symptom relationship among sleep quality, anxiety, and depression in Chinese patients with breast cancer: multidimensional data validation using PSQI versus actigraphy Journal of Cancer Survivorship
Recent News
 [1]. American Society of Human Genetics 2026 (ASHG 2026 @Montreal): Poster Presentaion
- Oct 2026 - @Presentaion Info - Board 1001
- A Multiomic Approach to Improve Prostate Cancer Risk Stratification in UK Biobank
 [2]. European Society of Human Genetics 2025 (ESHG 2025 @Milan): Oral Presentaion #European conference fellowship
- Mia Neri Award Best Talk of Cancer Research    Foundation Media
- Space 1+2: 11:00-12:30, Tuesday, 27 May - @Presentaion Info - C34.03 Advancing cancer prevention, detection and treatment
- Predicting prostate cancer by combining Prostate Specific Antigen (PSA) test results with Genetic Risk Scores (GRS)
 [3]. Cancer in Primary Care Research International (@Ca-PRI 2026) Conference: Oral Presentaion @Utrecht
- May 2026 - @Presentaion Info (Cancer Research UK ECR Award)
- Improved prostate cancer prediction/detection by combing PSA test results with Genetic risk scores(GRS/PRS)
Click to Connect  @jingzhan.bsky.social
Click to Connect  @JingzhanLu
Education
- University of Exeter (Medical School)             10/2023 - Now
- PhD Genetics and Genomics
- Genetics of Complex Traits Research Group
- Cancer diagnosis (DISCO) Group
- University College London (UCL)                 09/2021 - 12/2022
- MSc Health Data Science
- Human Genetics @UCL Lab
- Taiwan Tzu Chi University(College of Medicine)       09/2017 - 07/2021
- BEng Medical Informatics (Bioinfor Track)
Research
-
Improving the diagnosis of Prostate Cancer by combining prostate-specific antigen (PSA) test results with Genetic Risk Scores (GRS)
- Impact of control selection strategies on GWAS results – a study of the Schizophrenia and Bipolar Disorder in the UK Biobank
(Available on ResearchGate) –>
                                        Manhattan-Comparison Plot
- To develop a platform for the identification of Gram-stained images using Deep Convolutional Neutral Network
–>
- Molecular docking analysis of Ritonavir, Lopinavir, Atazanavir, Darunavir and TMC-31091 as SARS-CoV-2 3CLpro inhibitors
         Â
Social Media
I can be found on the following creative platforms
- Molecular docking analysis of Ritonavir, Lopinavir, Atazanavir, Darunavir and TMC-31091 as SARS-CoV-2 3CLpro inhibitors
- Github:Jingzhan-Lu
- LinkedIn:Jingzhan Lu
- Instagram:lujingzhan
Conference and Talk
- ESHG 2026, European Human Genetics Conference 2026, Gothenburg, Sweden
- CaPRI 2025, Cancer in Primary Care Research International (@Ca-PRI) Conference 2025: Oral Presentaion @Manchester
- Tuesday, 29 April - @Presentaion Info (Control Number: 19)
- Combing the PSA test with Polygenic Risk Scores (PRS/GRS) to improve the prostate cancer diagnosis in primary care
- UK Biobank Scientific Conference 2024: Poster Presentaion @London
-
- Predicting prostate cancer by combining Prostate Specific Antigen (PSA) test results with Genetic Risk Scores (GRS) in the UK Biobank
- Predicting prostate cancer by combining Prostate Specific Antigen (PSA) test results with Genetic Risk Scores (GRS) in the UK Biobank
- European Society of Human Genetics 2024 (ESHG 2024 @Berlin):Poster Presentaion
-
- Impact of control selection strategies on GWAS results: a study of Schizophrenia and Bipolar Disorder in the UK Biobank
- Impact of control selection strategies on GWAS results: a study of Schizophrenia and Bipolar Disorder in the UK Biobank
-
- P17.015.D - Poster Viewing Group D, Abstract available @ESHG Info
- P17.015.D - Poster Viewing Group D, Abstract available @ESHG Info
- SGGD 2024, Genetics of Diabetes, University of Exeter, UK
- ESHG 2024, European Human Genetics Conference 2024, Berlin, Germany
- 2022 AI-DLDA Summer School, University of Udine, Italy:YouTube Video
Contact
- Email: 106316153@gms.tcu.edu.tw